Krystal Biotech to Present at 44th Annual J.P. Morgan Healthcare Conference

Krystal Biotech (NASDAQ: KRYS) will participate in the 44th Annual J.P.

Rhea-AI Summary

Krystal Biotech (NASDAQ: KRYS) will participate in the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026 in San Francisco. Krish S. Krishnan, chairman and CEO, is scheduled to present at 10:30 am ET / 7:30 am PT and will host investor meetings throughout the day. A webcast of the presentation will be available beginning at 10:30 am ET / 7:30 am PT on January 12, 2026 and will be posted in the Investors section of the company website.

Argus Jan 5 session

-0.89% close to close Open Argus

Details

News Market Reaction – KRYS

On Jan 5, the day this news came out, KRYS closed 0.89% below the previous close.

Data tracked by StockTitan Argus for the Jan 5 session.

Market Context

This announcement signals Krystal Biotech’s participation in the 44th Annual J.P. Morgan Healthcare ...

Analysis

This announcement signals Krystal Biotech’s participation in the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026, with a management presentation at 10:30 am ET. It follows a period of strong operating performance, including robust VYJUVEK revenue and favorable regulatory milestones such as the updated label approval. Investors may focus on any incremental commentary delivered at the conference, but this notice itself introduces no new financial, clinical, or regulatory data.

Key Figures

Conference edition: 44th Conference date: January 12, 2026 Presentation time ET: 10:30 am ET +1 more

Conference edition

44th

44th Annual J.P. Morgan Healthcare Conference

Conference date

January 12, 2026

Scheduled presentation date in San Francisco

Presentation time ET

10:30 am ET

J.P. Morgan Healthcare Conference slot

Presentation time PT

7:30 am PT

Local time for conference presentation

Historical Context

5 past events · Latest: Nov 26

5 events

1. Nov 26

   Conference participation

   24h Move

   +0.8%

   Announcement of Evercore healthcare conference appearance and webcast details.

2. Nov 03

   Earnings results

   24h Move

   +0.2%

   Reported strong Q3 2025 revenue, margins, cash and global VYJUVEK rollout.

3. Oct 21

   Earnings schedule

   24h Move

   -2.6%

   Scheduled Q3 2025 results call and provided webcast and replay information.

4. Oct 14

   Regulatory designation

   24h Move

   +1.8%

   FDA platform technology designation for HSV-1 vector used in KB801.

5. Sep 15

   FDA label update

   24h Move

   +8.4%

   FDA approval of updated VYJUVEK label expanding eligibility and at-home use.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

PITTSBURGH, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the 44^th Annual J.P. Morgan Healthcare Conference on January 12, 2026, in San Francisco. Krish S. Krishnan, Chairman and Chief Executive Officer, is scheduled to give a presentation at 10:30 am ET / 7:30 am PT and host investor meetings throughout the day.

A webcast of the presentation will be available here beginning at 10:30 am ET / 7:30 am PT on Monday, January 12, 2026 and will be posted on the Investors section of the Company’s website.

About Krystal Biotech, Inc.

Krystal Biotech, Inc. (NASDAQ: KRYS) is a fully integrated, commercial-stage, global biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases with high unmet medical needs. VYJUVEK^®, the Company’s first commercial product, is the first-ever redosable gene therapy and the first genetic medicine approved in the United States, Europe, and Japan for the treatment of dystrophic epidermolysis bullosa. The Company is rapidly advancing a robust preclinical and clinical pipeline of investigational genetic medicines in respiratory, oncology, dermatology, ophthalmology, and aesthetics. Krystal Biotech is headquartered in Pittsburgh, Pennsylvania. For more information, please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and X (formerly Twitter).

CONTACT
Investors and Media:                                                                                        
Stéphane Paquette
Krystal Biotech
spaquette@krystalbio.com                                                                                   

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Krystal Biotech (KRYS) present at the J.P. Morgan Healthcare Conference?

Krystal Biotech will present on January 12, 2026 at 10:30 am ET / 7:30 am PT.

Who will present for Krystal Biotech (KRYS) at the January 12, 2026 conference?

Krish S. Krishnan, the company's chairman and CEO, is scheduled to give the presentation.

Will Krystal Biotech (KRYS) host investor meetings at the J.P. Morgan conference?

Yes, the company will host investor meetings throughout January 12, 2026.

How can investors watch Krystal Biotech's (KRYS) presentation on January 12, 2026?

A webcast will be available beginning at the presentation time and posted on the company's Investors section of its website.

What time is Krystal Biotech's (KRYS) webcast for investors in Pacific Time?

The webcast starts at 7:30 am PT on January 12, 2026.

Where will the Krystal Biotech (KRYS) presentation take place during the J.P. Morgan conference?

The presentation is part of the 44th Annual J.P. Morgan Healthcare Conference in San Francisco on January 12, 2026.